Literature DB >> 2388790

Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic.

D L Gibson1, S B Sheps, S H Uh, M T Schechter, A Q McCormick.   

Abstract

A recent population-based study in the Canadian province of British Columbia showed that, since the mid-1960s, there has been a significant increase in the incidence of retinopathy of prematurity-induced blindness in infants weighing 750 to 999 g at birth. To determine the impact of changing birth weight-specific survival on this new epidemic, all infants born in the province in the period 1952 through 1986 and known to the British Columbia Health Surveillance Registry as having retinopathy of prematurity-induced blindness were identified. In addition, the birth registration records for the 1,299 740 infants born in British Columbia in the same period and the death records of the 22,940 British Columbia-born infants who died in the province before the end of their first year of life were linked using a combination of probabilistic and manual record linkage techniques. These linked records and the records from the Health Surveillance Registry were used to calculate birth weight-specific incidence rates of retinopathy of prematurity-induced blindness in liveborn infants and first-year-of-life survivors. The rates, in 5-year intervals, showed that, in both liveborn infants and first-year survivors, the highest birth weight-specific rates occurred during the first epidemic of retinopathy of prematurity, which ended in British Columbia in 1954. Since the mid-to late-1960s, the incidence of retinopathy of prematurity-induced blindness in liveborn infants weighing less than 1000 g increased steadily whereas in infants weighting 1000 to 1499 g, incidence decreased slightly since the original epidemic ended. However, the experience of first-year-of-life survivors is substantially different.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2388790

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  32 in total

1.  Severe retinopathy of prematurity and its association with different rates of survival in infants of less than 1251 g birth weight.

Authors:  J Vyas; D Field; E S Draper; G Woodruff; A R Fielder; J Thompson; N J Shaw; D Clark; R Gregson; J Burke; G Durbin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

2.  Reduced incidence of retinopathy of prematurity.

Authors:  E Rowlands; A C Ionides; S Chinn; H Mackinnon; C C Davey
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

Review 3.  Screening for retinopathy of prematurity.

Authors:  A R Fielder; M I Levene
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

4.  Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser.

Authors:  I A Pearce; F C Pennie; L M Gannon; A M Weindling; D I Clark
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

5.  Blood gases and retinopathy of prematurity: the ELGAN Study.

Authors:  Alisse K Hauspurg; Elizabeth N Allred; Deborah K Vanderveen; Minghua Chen; Francis J Bednarek; Cynthia Cole; Richard A Ehrenkranz; Alan Leviton; Olaf Dammann
Journal:  Neonatology       Date:  2010-07-30       Impact factor: 4.035

Review 6.  Retinopathy of prematurity.

Authors:  E Bossi; F Koerner
Journal:  Intensive Care Med       Date:  1995-03       Impact factor: 17.440

7.  Diode laser for retinopathy of prematurity--early outcome.

Authors:  M Goggin; M O'Keefe
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

8.  Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity.

Authors:  Shu-Ching Shih; Meihua Ju; Nan Liu; Lois E H Smith
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

9.  Follow-up study on premature infants with and without retinopathy of prematurity.

Authors:  R Robinson; M O'Keefe
Journal:  Br J Ophthalmol       Date:  1993-02       Impact factor: 4.638

10.  Decursin inhibits retinal neovascularization via suppression of VEGFR-2 activation.

Authors:  Jeong Hun Kim; Jin Hyoung Kim; You Mie Lee; Eun-Mi Ahn; Kyu-Won Kim; Young Suk Yu
Journal:  Mol Vis       Date:  2009-09-12       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.